HUP0101597A2 - Reprodukálható hatóanyag-felszabadulású, gatifloxacint vagy gyógyászatilag alkalmas sóit vagy hidrátjait tartalmazó orális gyógyszerformák - Google Patents
Reprodukálható hatóanyag-felszabadulású, gatifloxacint vagy gyógyászatilag alkalmas sóit vagy hidrátjait tartalmazó orális gyógyszerformákInfo
- Publication number
- HUP0101597A2 HUP0101597A2 HU0101597A HUP0101597A HUP0101597A2 HU P0101597 A2 HUP0101597 A2 HU P0101597A2 HU 0101597 A HU0101597 A HU 0101597A HU P0101597 A HUP0101597 A HU P0101597A HU P0101597 A2 HUP0101597 A2 HU P0101597A2
- Authority
- HU
- Hungary
- Prior art keywords
- hydrates
- active ingredient
- gatifloxacin
- suitable salts
- pharmaceutically suitable
- Prior art date
Links
- XUBOMFCQGDBHNK-JTQLQIEISA-N (S)-gatifloxacin Chemical compound FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCN[C@@H](C)C1 XUBOMFCQGDBHNK-JTQLQIEISA-N 0.000 title abstract 3
- 229960003923 gatifloxacin Drugs 0.000 title abstract 3
- 150000004677 hydrates Chemical class 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- 239000011230 binding agent Substances 0.000 abstract 3
- 239000000945 filler Substances 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 3
- 239000007884 disintegrant Substances 0.000 abstract 2
- 239000000314 lubricant Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000008385 outer phase Substances 0.000 abstract 2
- -1 if applicable Substances 0.000 abstract 1
- 239000008384 inner phase Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány tárgya gatifloxacint vagy gyógyászatilag alkalmas sóitvagy hidrátjait és a töltőanyagok, kötőanyagok, lubrikánsok ésszétesést elősegítő anyagok csoportjába tartozó segédanyagot vagykeverékeiket tartalmazó, orális adagolásra szolgáló többfázisúfelépítésű orális gyógyszerforma, amely hatóanyagként gatifloxacintvagy gyógyászatilag alkalmas sóit vagy hidrátjait és segédanyagkéntvalamely kötőanyagot, töltőanyagot, szétesést elősegítő anyagot ésezek keverékét tartalmazó belső fázist és legalább egy külső fázisttartalmaz, amely külső fázis(ok) kötelezően legalább egy széteséstelősegítő anyagból és további segédanyagként legalább egylubrikánsból, adott esetben töltőanyagokból és/vagy kötőanyagokbóláll(nak). Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19820801A DE19820801A1 (de) | 1998-05-09 | 1998-05-09 | Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten |
PCT/EP1999/002893 WO1999058129A1 (de) | 1998-05-09 | 1999-04-29 | Orale arzneiformen mit reproduzierbarer wirkstofffreisetzung von gatifloxacin oder pharmazeutisch verwendbaren salzen oder hydraten |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0101597A2 true HUP0101597A2 (hu) | 2001-11-28 |
HUP0101597A3 HUP0101597A3 (en) | 2003-01-28 |
Family
ID=7867223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0101597A HUP0101597A3 (en) | 1998-05-09 | 1999-04-29 | Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates |
Country Status (28)
Country | Link |
---|---|
US (1) | US6291462B1 (hu) |
EP (1) | EP1077703B1 (hu) |
JP (1) | JP2002514600A (hu) |
KR (1) | KR100587210B1 (hu) |
CN (1) | CN1198615C (hu) |
AR (1) | AR019279A1 (hu) |
AT (1) | ATE235242T1 (hu) |
AU (1) | AU753482B2 (hu) |
BR (1) | BR9910350A (hu) |
CA (1) | CA2325636A1 (hu) |
CO (1) | CO5050341A1 (hu) |
DE (2) | DE19820801A1 (hu) |
DK (1) | DK1077703T3 (hu) |
ES (1) | ES2195573T3 (hu) |
HK (1) | HK1033281A1 (hu) |
HU (1) | HUP0101597A3 (hu) |
IL (1) | IL139512A0 (hu) |
MY (1) | MY118569A (hu) |
NO (1) | NO20005385L (hu) |
NZ (1) | NZ507968A (hu) |
PE (1) | PE20000480A1 (hu) |
PL (1) | PL343936A1 (hu) |
PT (1) | PT1077703E (hu) |
RU (1) | RU2226394C2 (hu) |
SK (1) | SK16772000A3 (hu) |
UA (1) | UA60364C2 (hu) |
WO (1) | WO1999058129A1 (hu) |
ZA (1) | ZA200006440B (hu) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2387016C (en) | 1999-10-08 | 2010-09-28 | William H. Miller | Acrylamide derivatives as fab i inhibitors |
US6413969B1 (en) * | 2000-09-13 | 2002-07-02 | Bristol-Myers Squibb Company | Gatifloxacin pentahydrate |
DK1560584T3 (da) * | 2001-04-06 | 2009-05-18 | Affinium Pharm Inc | Fab I inhibitorer |
US6589955B2 (en) * | 2001-06-20 | 2003-07-08 | Bristol-Myers Squibb Company | Pediatric formulation of gatifloxacin |
JP4859460B2 (ja) * | 2002-12-06 | 2012-01-25 | アフィニウム ファーマシューティカルズ, インク. | ヘテロ環化合物、その製造方法および治療におけるその使用 |
CA2519429C (en) | 2003-03-17 | 2013-08-06 | Affinium Pharmaceuticals, Inc. | Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics |
US20050031683A1 (en) * | 2003-08-04 | 2005-02-10 | Ashish Kapoor | Solid pharmaceutical composition |
WO2005021000A1 (en) * | 2003-08-28 | 2005-03-10 | Ranbaxy Laboratories Limited | Solid oral dosage forms of gatifloxacin |
PE20142101A1 (es) * | 2004-03-17 | 2014-12-27 | Novartis Ag | Composiciones farmaceuticas de aliskiren |
DK1828167T3 (da) | 2004-06-04 | 2014-10-20 | Debiopharm Int Sa | Acrylamidderivater som antibiotiske midler |
US20060247255A1 (en) * | 2005-05-02 | 2006-11-02 | Patel Satishkumar A | Method for preparing a stable gatifloxacin composition |
CN101277670B (zh) * | 2005-08-02 | 2012-05-30 | 巴克斯特国际公司 | 用于医学产品的氧指示剂 |
US20090156578A1 (en) * | 2005-12-05 | 2009-06-18 | PAULS Henry | 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents |
EP2054422B1 (en) | 2006-07-20 | 2017-06-14 | Debiopharm International SA | Acrylamide derivatives as fab i inhibitors |
CN100415212C (zh) * | 2006-07-21 | 2008-09-03 | 哈药集团制药总厂 | 一种含乳酸卡德沙星的口服制剂 |
CA2563690C (en) * | 2006-10-12 | 2014-10-07 | Pharmascience Inc. | Pharmaceutical compositions comprising intra- and extra- granular fractions |
EP2125802A4 (en) * | 2007-02-16 | 2014-08-20 | Debiopharm Int Sa | SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS |
IN2014KN02915A (hu) | 2012-06-19 | 2015-05-08 | Debiopharm Int Sa | |
TN2018000293A1 (en) | 2016-02-26 | 2020-01-16 | Debiopharm Int Sa | Medicament for treatment of diabetic foot infections |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH089597B2 (ja) * | 1986-01-21 | 1996-01-31 | 杏林製薬株式会社 | 選択毒性に優れた8‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法 |
MY110880A (en) * | 1991-01-30 | 1999-06-30 | The Wellcome Foundation Ltd | Water-dispersible tablets |
GB9109862D0 (en) * | 1991-05-08 | 1991-07-03 | Beecham Lab Sa | Pharmaceutical formulations |
US5436253A (en) * | 1993-09-08 | 1995-07-25 | Daiichi Pharmaceutical Co., Ltd. | Pyridonecarboxylic acid derivatives and mycotic infections |
EP0797987B1 (en) * | 1994-12-19 | 2003-10-15 | Daiichi Pharmaceutical Co., Ltd. | Sustained-release granular preparation and process for producing the same |
US5945124A (en) * | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
US5837292A (en) * | 1996-07-03 | 1998-11-17 | Yamanouchi Europe B.V. | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
-
1998
- 1998-05-09 DE DE19820801A patent/DE19820801A1/de not_active Withdrawn
-
1999
- 1999-04-22 MY MYPI99001588A patent/MY118569A/en unknown
- 1999-04-29 PT PT99923491T patent/PT1077703E/pt unknown
- 1999-04-29 KR KR1020007012442A patent/KR100587210B1/ko not_active IP Right Cessation
- 1999-04-29 NZ NZ507968A patent/NZ507968A/xx unknown
- 1999-04-29 CN CNB998059897A patent/CN1198615C/zh not_active Expired - Fee Related
- 1999-04-29 AT AT99923491T patent/ATE235242T1/de not_active IP Right Cessation
- 1999-04-29 SK SK1677-2000A patent/SK16772000A3/sk unknown
- 1999-04-29 WO PCT/EP1999/002893 patent/WO1999058129A1/de active IP Right Grant
- 1999-04-29 ES ES99923491T patent/ES2195573T3/es not_active Expired - Lifetime
- 1999-04-29 AU AU40352/99A patent/AU753482B2/en not_active Ceased
- 1999-04-29 IL IL13951299A patent/IL139512A0/xx unknown
- 1999-04-29 JP JP2000547980A patent/JP2002514600A/ja active Pending
- 1999-04-29 HU HU0101597A patent/HUP0101597A3/hu unknown
- 1999-04-29 DK DK99923491T patent/DK1077703T3/da active
- 1999-04-29 PL PL99343936A patent/PL343936A1/xx unknown
- 1999-04-29 CA CA002325636A patent/CA2325636A1/en not_active Abandoned
- 1999-04-29 US US09/700,055 patent/US6291462B1/en not_active Expired - Fee Related
- 1999-04-29 RU RU2000130202/15A patent/RU2226394C2/ru not_active IP Right Cessation
- 1999-04-29 DE DE59904737T patent/DE59904737D1/de not_active Expired - Fee Related
- 1999-04-29 EP EP99923491A patent/EP1077703B1/de not_active Expired - Lifetime
- 1999-04-29 UA UA2000126915A patent/UA60364C2/uk unknown
- 1999-04-29 BR BR9910350-8A patent/BR9910350A/pt not_active IP Right Cessation
- 1999-05-03 PE PE1999000361A patent/PE20000480A1/es not_active Application Discontinuation
- 1999-05-04 CO CO99027132A patent/CO5050341A1/es unknown
- 1999-05-07 AR ARP990102177A patent/AR019279A1/es active IP Right Grant
-
2000
- 2000-10-26 NO NO20005385A patent/NO20005385L/no not_active Application Discontinuation
- 2000-11-08 ZA ZA200006440A patent/ZA200006440B/en unknown
-
2001
- 2001-06-14 HK HK01104097A patent/HK1033281A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL139512A0 (en) | 2001-11-25 |
PT1077703E (pt) | 2003-08-29 |
BR9910350A (pt) | 2001-09-25 |
UA60364C2 (uk) | 2003-10-15 |
AU4035299A (en) | 1999-11-29 |
HUP0101597A3 (en) | 2003-01-28 |
HK1033281A1 (en) | 2001-08-24 |
EP1077703B1 (de) | 2003-03-26 |
CA2325636A1 (en) | 1999-11-18 |
ES2195573T3 (es) | 2003-12-01 |
CN1198615C (zh) | 2005-04-27 |
WO1999058129A1 (de) | 1999-11-18 |
NO20005385D0 (no) | 2000-10-26 |
DE59904737D1 (de) | 2003-04-30 |
AU753482B2 (en) | 2002-10-17 |
PL343936A1 (en) | 2001-09-10 |
DE19820801A1 (de) | 1999-11-25 |
KR100587210B1 (ko) | 2006-06-08 |
SK16772000A3 (sk) | 2001-05-10 |
US6291462B1 (en) | 2001-09-18 |
JP2002514600A (ja) | 2002-05-21 |
KR20010043408A (ko) | 2001-05-25 |
DK1077703T3 (da) | 2003-06-23 |
PE20000480A1 (es) | 2000-05-20 |
RU2226394C2 (ru) | 2004-04-10 |
NO20005385L (no) | 2000-10-26 |
ZA200006440B (en) | 2002-02-08 |
AR019279A1 (es) | 2002-02-13 |
CO5050341A1 (es) | 2001-06-27 |
CN1300216A (zh) | 2001-06-20 |
ATE235242T1 (de) | 2003-04-15 |
EP1077703A1 (de) | 2001-02-28 |
MY118569A (en) | 2004-12-31 |
NZ507968A (en) | 2002-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0101597A2 (hu) | Reprodukálható hatóanyag-felszabadulású, gatifloxacint vagy gyógyászatilag alkalmas sóit vagy hidrátjait tartalmazó orális gyógyszerformák | |
HUP0000138A2 (hu) | Szabályozott hatóanyag-leadású opioid analgetikumokat tartalmazó gyógyászati készítmények | |
HUP0203176A2 (hu) | Szimetikont tartalmazó orális, szilárd adagolási forma | |
HUP9903734A2 (hu) | Szabályozott felszabadulású, orális gyógyszerkészítmények és eljárás ezek előállítására | |
IL131818A (en) | Pharmaceutical composition for oral administration of a n-piperidino-3-pyrazolecarboxamide derivative, its salts and solvates and their preparation | |
IS1889B (is) | Innöndunarefnasambönd | |
HUP0203500A2 (en) | Storage system for medicaments in powder form and inhaler provided therewith | |
DE1001772T1 (de) | Verbesserte verabreichungstechnik für multiple medikamentengaben | |
HUP0203556A2 (hu) | Oxkarbazepint tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0302571A2 (hu) | Szerves vegyületek keverékét tartalmazó gyógyszerkészítmény légúti betegségek kezelésére | |
BR9810124A (pt) | Um itraconazol exibindo solibilidade incrementada, o método de preparação do mesmo e a composição farmacêutica para administração oral contendo o mesmo | |
WO2005065069A3 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
ATE224717T1 (de) | Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin | |
MY123193A (en) | Novel 2-(iminomethyl)amino-phenyl derivatives,preparation,application as medicines and compositions containing same | |
MY124146A (en) | Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same | |
UA41909C2 (uk) | Використання комбінації сполук для інгібірування остеопорозу, фармацевтичний препарат | |
PL333524A1 (en) | Improved prolonged release pharmaceutic preparation for administration of nephadosone, oral dosage form thereof and improved nephadosone administration method | |
HUP0301390A2 (hu) | Valzartánt tartalmazó orális gyógyászati készítmény | |
HUP0202862A2 (hu) | A loteprednol és antihisztaminok új kombinációját tartalmazó gyógyszerkészítmény | |
IL158668A0 (en) | Deuterated 3-piperidinopropiophenone and medicaments containing said compounds | |
HUP0003757A2 (hu) | Levosimendant tartalmazó orális gyógyászati készítmények | |
BR9815248A (pt) | Sistema monolìtico contendo um ou mais medicamentos, consistindo de três camadas com diferentes mecanismos de liberação | |
HUP0400115A2 (hu) | Gyógyászati készítmény fulvesztrant intramuszkuláris beadására | |
HUP0300295A2 (hu) | Helyettesített benzamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0004900A2 (hu) | Mozgászavarok kezelésére szolgáló, hatóanyagként NMDA-receptor antagonista hatású piperidinszármazékokat tartalmazó gyógyszerkészítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |